Nuwellis, Inc. (NUWE) vs Nexalin Technology, Inc. (NXL)
Nuwellis, Inc. and Nexalin Technology, Inc. are both Medical Devices companies. Nexalin Technology, Inc. is the larger, with a market value of $3.6M against $2.9M — 1.2× the size. Nexalin Technology, Inc. grew revenue faster over the last twelve months: 24.3% against 8.36%. Nuwellis, Inc. has the higher net margin (−125.6% vs −4,138.5%) and the higher return on invested capital (0.00% vs −1,108.8%). Across the 16 metrics below, Nuwellis, Inc. leads on 11 and Nexalin Technology, Inc. on 5.
Valuation
Profitability
| Metric | NUWE | NXL | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.69% | 86.14% | 56.01% |
| Operating margin | (142.87%) | (4,201.66%) | (15.03%) |
| Net margin | (125.57%) | (4,138.49%) | (20.40%) |
| Free cash flow margin | (140.67%) | (2,917.96%) | (7.24%) |
| Return on equity | 205.50% | (240.25%) | (15.32%) |
| Return on assets | (123.52%) | (187.89%) | (19.72%) |
| Return on invested capital | 0.00% | (1,108.82%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack